Some Ky. counties using settlement money to make new opioid-withdrawal treatment available to a small number of residents

The device uses low-intensity electrical pulses to reduce withdrawal symptoms. (WDRB photo, from NET Recovery Corp.)

The device uses low-intensity electrical pulses to reduce

withdrawal symptoms. (WDRB photo, from NET Recovery Corp.)

This story has been updated.

By Melissa Patrick

Kentucky Health News

four Kentucky counties are making a new treatment to reduce opioid-withdrawal symptoms available free to a few of their residents, using money from the state's settlements with drug manufacturers and distributors.

Three more counties are in the queue, and others are in discussion. Counties and most Kentucky cities get half the settlement money, more than $900 million over the next 15 years.

Meade, Scott, Bullitt and Franklin counties have committed settlement money for the treatment of limited numbers of residents with opioid-use disorder. Letcher and Shelby counties are in the process of final approval, and Bell County is in discussions with NET Recovery Corp.

The company is named for the "neuro-electric therapy" that its non-invasive "NET Device" delivers. Asked about the device's success rate, company spokesman Jeff Lott said, "A person treated with the NET Device for more than one day is significantly more likely to remain opioid-free without medication."

The amount of money committed to NET Recovery for treatment from each county varies. 

Company spokesman Jeff Lott said since the NET Device gained U.S. Food and Drug Administration approval, the cost for a treatment is $5,500. He said in an email that some counties received a discount if they started negotiations before FDA approval. 

"If we had already started negotiations with an amount for less than $5,500, we are still honoring that price for the first contract," Lott said. 

In Bullitt County, CFO and Community Development Director Keith Griffee said the county has signed a service contract for $50,000 to provide treatment services for 15 residents, or $3,333 per person.

The same per-person figure applies in Meade County, where Treasurer Tammy Graham said the county had allocated $60,000 of its opioid-abatement money for services to 18 residents.

Scott County Court Clerk Stacy Hamilton said Scott County had approved $110,000 for 34 residents. That amounts to $3,235 per person.

Franklin County's $75,000 contract is for 15 patients at $5,000 each, The State Journal reports.  

Lott said Shelby County plans to vote on its contract Tuesday, July 2. He said the county is looking to commit $100,000 to the program. He did not say how many residents this contract would serve. 

He said Franklin County had voted to approve a service agreement for $75,000 to cover 15 patients, but the contract has not been signed. That amounts to $5,000 per person.

Lott said NET Recovery is still in talks with Letcher County, which had backed out of its initial $125,000 contract with NET Recovery.  Lott said the two-year contracts allow either party to terminate the contract. 

"It is my understanding that they still want to participate for a lesser amount," Lott said.

He said the company is working to get other counties "to help their people get a brand new FDA-cleared treatment that can change the lives of their residents."

"We are counting on the counties to help fund this," Lott said. "If anyone has a question about how they can get their county to sponsor it, they can email me. I'd love to talk them through it." (His email address is jeff.lott@netrecovery.net.)

Isaiah House lauds NET Device

The neuro-electric therapy to reduce withdrawal symptoms will be offered exclusively through Isaiah House, a Christian-based rehabilitation center based in Harrodsburg.

The NET Device (Photo from company website)

Mike Cox, chief operating officer of Isaiah House, said the treatment involves taping tiny electrodes behind the participant's mastoid process, behind the ear, to deliver a carefully programmed series of tiny electrical pulses that stimulate the production of the body's natural neurotransmitters, such as endorphins.

"We know that those neurotransmitters become depleted and replaced by the drug" chosen by those with opioid-use disorder, Cox said. "When a person tries to stop taking the drug, then he or she begins to experience intense cravings and the body goes into withdrawal. It is that terrible experience of intense cravings, that horrible sickness that keeps people from stopping using the substance that keeps them using. Not for the euphoria of it, but just to survive." 

He said they will have 30 reusable units on hand for the treatment, which lasts five to seven days.

While the device will be helpful, Cox said, it is not the single solution. 

"We see it as a tool to help them on the front end of treatment," he said. "This device is a new tool in the toolbox to really help people overcome the fear and experience of being sick from withdrawal and the intense cravings, which are . . . really the reasons why many people are afraid to get treatment." 

According to state data, in 2023, nearly 80% of Kentucky's overdose deaths involved opioids.

Medications are available to treat opioid-use disorder, but Cox noted that many people use more than one substance. And while the clinical trial of the NET Device focused on opiates, he said it also helps with the withdrawal symptoms of other drugs, from nicotine to methamphetamine.

"We know the device to be effective for all drugs," Cox said. "They have specific programming for each type of drug, which makes this device unique. . . . The additional upside to this device over medications is that it addresses the concerns of abuse and diversion."

Later, he said, "We have witnessed, really the positive impact of this device on a lot of people without any negative side effects. And, FDA approval is further evidence of the efficacy of this device in reducing cravings and withdrawal symptoms."

Cox said Isaiah House will only be paid a "small amount" for the additional work required by his staff to offer the therapy.

Who qualifies for it? 

Cox said participants will be considered for the NET Device on a case-by-case basis. "We just want to help people," he said.

Because insurance does not pay for the treatment, Lott said, "At this time, we're only focusing on treating people from counties who have paid for it or anyone can choose to pay and be treated." 

Bullitt County's contract says the participant must be diagnosed with opioid-use disorder, be admitted on a separately paid basis into a participating service program with a residential drug-addiction treatment facility, be a resident of the contracted county, and meet the clinical eligibility for the treatment, including a desire to participate in the program. 

Lott added that a participant must also be 18, and cannot be pregnant or have a pacemaker.

Cox said Isaiah House is starting the program in one of its men's facilities in Washington County and one of its women's facilities in Mercer County. Eventually, he said the treatment would be offered at all of their residential facilities.